Cookie and Privacy Settings

This website uses cookies to enable essential functions like the user login and sessions. We also use cookies and third-party tools to improve your surfing experience on preplounge.com. You can choose to activate only essential cookies or all cookies. You can always change your preference in the cookie and privacy settings. This link can also be found in the footer of the site. If you need more information, please visit our privacy policy.

Data processing in the USA: By clicking on "I accept", you also consent, in accordance with article 49 paragraph 1 sentence 1 lit. GDPR, to your data being processed in the USA (by Google LLC, Facebook Inc., LinkedIn Inc., Stripe, Paypal).

Manage settings individually I accept
1

How to structure a Go-to-market strategy in Pharma and its specificities

Hello everyone,

I am kind of struggling on a case of a Go-to-market strategy in pharma, a type of case I am not familiar with: The clients wants to launch an already approved and used drug (in one therapy area) to a new therapy area. They ask us to plan a whole go-to-market strategy project in order to maximize the pricing & market access success.

What we know:
We have some data about the drug, the dosing, the competitors, etc.
The market is EU5.
But we don't know if the drug is approved for the new indication yet.

My questions are:
1) How should I structure my approach? 4Ps? Pricing/Channels/Time to market/...
2) Do i need to chose the scope, to chose a particular country to start? If yes, how should I chose it? Based on my knowledge?
3) What would be the specificities of the pharma industry to take into account here and how? Regulatory aspects/KOLs(GPs,...)/Reimbursement/Health-economic agencies/...

Hello everyone,

I am kind of struggling on a case of a Go-to-market strategy in pharma, a type of case I am not familiar with: The clients wants to launch an already approved and used drug (in one therapy area) to a new therapy area. They ask us to plan a whole go-to-market strategy project in order to maximize the pricing & market access success.

What we know:
We have some data about the drug, the dosing, the competitors, etc.
The market is EU5.
But we don't know if the drug is approved for the new indication yet.

My questions are:
1) How should I structure my approach? 4Ps? Pricing/Channels/Time to market/...
2) Do i need to chose the scope, to chose a particular country to start? If yes, how should I chose it? Based on my knowledge?
3) What would be the specificities of the pharma industry to take into account here and how? Regulatory aspects/KOLs(GPs,...)/Reimbursement/Health-economic agencies/...

1 answer

  • Upvotes
  • Date ascending
  • Date descending
Best Answer

Hi there,

I suggest to you this framework. PLEASE DON’T HESITATE TO TAILOR IT TO YOUR SPECIFIC DRUG.

1- Market attractivity

a- Demand :

Who are the potential clients of this drug in EU5? (segments -> End user, hospitals, clinics, doctors, drug stores…? )

What is the market size of this drug in Europe? What is the potential growth of this market?

b- Offer:

Who are the competitors in EU5 who are selling a similar drug/therapy for the same disease? What are their market share?

c- Other factors:

Is it easy to get approval from authorities? What would be the time span to get this approval? Should our client get an approval from each country of the EU5 or only one approval from the European Medicines Agency?

Does the product have a patent in EU?

What are the risks associated to this drug that were encountered in the countries where it was already commercialized?

Is it easy for this drug to be reimbursed from public authorities (Social Security organism in France for instance) and insurance companies?

etc

2- Go-To-Market Strategy

a- Drug and customers

What is the value proposition of this drug?

What is the time-to-market?

Who are the targeted customers from the identified market ? (refine your customers segmentation)

Is this drug profitable ? (Projected volume sold x Price – Costs [don’t forget R&D, marketing costs and insurance costs to cover potential conflicts] -> pricing and profitability mini-case)

b- Marketing plan

How to promote easily and effectively the targeted customers ? (seminars, advertising, sales teams going directly to customers? …)

c- Channels selection

What are the best channels to reach the maximum number of customers? (If B2C then online, drug stores…If B2B then online platform to sell to hospitals/clinics + drug stores + doctors, wholesalers... )

Hi there,

I suggest to you this framework. PLEASE DON’T HESITATE TO TAILOR IT TO YOUR SPECIFIC DRUG.

1- Market attractivity

a- Demand :

Who are the potential clients of this drug in EU5? (segments -> End user, hospitals, clinics, doctors, drug stores…? )

What is the market size of this drug in Europe? What is the potential growth of this market?

b- Offer:

Who are the competitors in EU5 who are selling a similar drug/therapy for the same disease? What are their market share?

c- Other factors:

Is it easy to get approval from authorities? What would be the time span to get this approval? Should our client get an approval from each country of the EU5 or only one approval from the European Medicines Agency?

Does the product have a patent in EU?

What are the risks associated to this drug that were encountered in the countries where it was already commercialized?

Is it easy for this drug to be reimbursed from public authorities (Social Security organism in France for instance) and insurance companies?

etc

2- Go-To-Market Strategy

a- Drug and customers

What is the value proposition of this drug?

What is the time-to-market?

Who are the targeted customers from the identified market ? (refine your customers segmentation)

Is this drug profitable ? (Projected volume sold x Price – Costs [don’t forget R&D, marketing costs and insurance costs to cover potential conflicts] -> pricing and profitability mini-case)

b- Marketing plan

How to promote easily and effectively the targeted customers ? (seminars, advertising, sales teams going directly to customers? …)

c- Channels selection

What are the best channels to reach the maximum number of customers? (If B2C then online, drug stores…If B2B then online platform to sell to hospitals/clinics + drug stores + doctors, wholesalers... )

Related case(s)

Hot Wheels

Solved 5.5k times
Hot Wheels Problem definition: Our client is Korean Car Parts (KCP), a multi-national original equipment manufacturer (OEM) of car parts based in Korea. They've recently seen a decline in profits and have brought us in to understand how to address this falling profitability.
4.6 5 297
| Rating: (4.6 / 5.0)

Problem definition: Our client is Korean Car Parts (KCP), a multi-national original equipment manufacturer (OEM) of car parts based in Korea. They've recently seen a decline in profits and have brought us in to understand how to address this falling profitability. Open whole case

Cutting Carbs - Divestiture in the Electrical Power Market

Solved 1.8k times
Cutting Carbs - Divestiture in the Electrical Power Market Our client is Energy England, one of northern England’s largest electric utility companies. They were created over the past decade through an aggressive series of mergers of existing utility companies each specializing in a single energy generation source. Recently, the CEO has embarked on an initiative to return to the core of the business. She is looking to increase free cash flow and cash reserves in order to prepare the business for evolving future trends.   The following can be verbally provided to interviewee if asked: Energy England is made up of assets across the energy-generation space. These include coal, gas, nuclear, and wind We are looking to divest from just one of our previous acquisitions (i.e one target is sufficient) There are no specific goals/metrics – the client trusts our judgement
4.3 5 37
| Rating: (4.3 / 5.0)

Our client is Energy England, one of northern England’s largest electric utility companies. They were created over the past decade through an aggressive series of mergers of existing utility companies each specializing in a single energy generation source. Recently, the CEO has embarked on an initi ... Open whole case

CoffeeWorks reusable cups

Solved 1.2k times
CoffeeWorks reusable cups CoffeeWorks is one of the leading coffee retail chains in the UK. The client is planning to introduce reusable cups with an aim to decrease the consumption of single-use disposable cups. The main goal of the client is to enhance their brand image as a sustainable retailer without harming current profitability levels. Thus, they approached us to check whether they should go ahead with their plan.
4.2 5 52
| Rating: (4.2 / 5.0)

CoffeeWorks is one of the leading coffee retail chains in the UK. The client is planning to introduce reusable cups with an aim to decrease the consumption of single-use disposable cups. The main goal of the client is to enhance their brand image as a sustainable retailer without harming current pro ... Open whole case